Defining and emulating target trials of the effects of postexposure vaccination using observational data
Lipsitch, M.; Boyer, C.
Show abstract
Postexposure vaccination has the potential to prevent or modify the course of clinical disease among those exposed to a pathogen. However, due to logistical constraints, postexposure vaccine trials have been difficult to implement in practice. In place of trials, investigators have used observational data to estimate the effectiveness or optimal timing window for postexposure vaccines, but the relationship between these analyses and those that would be conducted in a trial is often unclear. Here, we define several possible target trials for postexposure vaccination and show how, under certain conditions, they can be emulated using observational data. We emphasize the importance of the incubation period and the timing of vaccination in trial design and emulation. As an example, we specify a protocol for postexposure vaccination against mpox and provide a step-by-step description of how to emulate it using data from a healthcare database or contact tracing program. We further illustrate some of the benefits of the target trial approach through simulation.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Use of recently vaccinated individuals to detect bias in test-negative case-control studies of COVID-19 vaccine effectiveness 96%
- Incorporating efficacy data from initial trials into subsequent evaluations of vaccines against respiratory syncytial virus 96%
- Estimating vaccine efficacy against transmission via effect on viral load 96%
Similar papers in this journal
Similar papers in this journal
- Statistical Methods for Estimating the Protective Effects of Immune Markers Using Test-Negative Designs 94%
- Estimating protection afforded by prior infection in preventing reinfection: Applying the test-negative study design 93%
- Misclassification of yellow fever vaccination status revealed through hierarchical Bayesian modeling 93%
Similar papers in this journal
- Estimation of Vaccine Efficacy for Variants that Emerge After the Placebo Group Is Vaccinated 97%
- Test-Negative Designs with Multiple Testing Sources 95%
- A Double Machine Learning Approach for the Evaluation of COVID-19 Vaccine Effectiveness under the Test-Negative Design: Analysis of Québec Administrative Data 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.